The effect of frequent hemodialysis on matrix metalloproteinases, their tissue inhibitors, and FGF23: Implications for blood pressure and left ventricular mass modification in the Frequent Hemodialysis Network trials.

MLA

Chan, Christopher T., et al. “The Effect of Frequent Hemodialysis on Matrix Metalloproteinases, Their Tissue Inhibitors, and FGF23: Implications for Blood Pressure and Left Ventricular Mass Modification in the Frequent Hemodialysis Network Trials.” Hemodialysis International. International Symposium on Home Hemodialysis, vol. 24, no. 2, Apr. 2020, pp. 162–74. EBSCOhost, https://doi.org/10.1111/hdi.12807.

APA

Chan, C. T., Kaysen, G. A., Beck, G. J., Li, M., Lo, J. C., Rocco, M. V., & Kliger, A. S. (2020). The effect of frequent hemodialysis on matrix metalloproteinases, their tissue inhibitors, and FGF23: Implications for blood pressure and left ventricular mass modification in the Frequent Hemodialysis Network trials. Hemodialysis International. International Symposium on Home Hemodialysis, 24(2), 162–174. https://doi.org/10.1111/hdi.12807

Chicago

Chan, Christopher T, George A Kaysen, Gerald J Beck, Minwei Li, Joan C Lo, Michael V Rocco, and Alan S Kliger. 2020. “The Effect of Frequent Hemodialysis on Matrix Metalloproteinases, Their Tissue Inhibitors, and FGF23: Implications for Blood Pressure and Left Ventricular Mass Modification in the Frequent Hemodialysis Network Trials.” Hemodialysis International. International Symposium on Home Hemodialysis 24 (2): 162–74. doi:10.1111/hdi.12807.